Abstract: The invention relates to novel azetidine compounds of formula (I), wherein R1, R2, and X are as described in the description and their use as orexin receptor antagonists.
Type:
Grant
Filed:
August 15, 2007
Date of Patent:
August 9, 2011
Assignee:
Actelion Pharmaceuticals Ltd.
Inventors:
Hamed Aissaoui, Christoph Boss, Markus Gude, Ralf Koberstein, Thierry Sifferlen